ArticleVascular health and risk management2026
Coronary Artery Disease Risk Assessment by Coronary Artery Calcium Scoring in Asymptomatic Thai People with Diabetes Mellitus.
Article in Vascular health and risk management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: People with diabetes mellitus (DM) remain at high risk of cardiovascular (CV) disease. The use of coronary artery calcium (CAC) has been demonstrated as the most powerful CV risk indicator and surrogate marker for the overall vascular health in the asymptomatic population. Material and Methods: This study aimed to find the severity of CAC in asymptomatic Thai people with DM, evaluate the correlation of the severity CAC risk scoring system with different CV risk scores, and examine the impacts of CAC testing on patient managements. ABC control, defined as the proportion of individuals meeting glycemic, blood pressure, and LDL cholesterol targets together, was assessed at 6 months after the CAC measurement. Results: A total of 157 patients (female 45.2%, T2D 93.0%, mean age 61.7±13.3 years, mean DM duration 12.4±10.6 years, BMI 26.4±4.8 kg/m Conclusion: CAC is an effective tool for CV risk stratification among asymptomatic people with DM and could improve metabolic target attainment rates. Currently available clinical risk assessment models including diabetes-specific risk scores correlated weakly with results from CAC testing among Thai people with DM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.